Echoiq Limited has released a press release.
Echo IQ Announces Positive Results From US Clinical Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from EchoIQ
- Amendment to Appendix 4C
- Quarterly Activities/Appendix 4C Cash Flow Report - Sept
- Reinstatement to Official Quotation
- Echo IQ Selected for HeartX Accelerator & Funding
- Suspension from Official Quotation
Later from EchoIQ
- Echo IQ Launches EchoSolv for Immediate Distribution
- Positive Interim Results From Clinical Trial at St Vincents
- Quarterly Activities/Appendix 4C Cash Flow Report - Dec
- Amendment to Quarterly Report
- Appendix 4D 31 December 2022
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ